In patients with tinnitus, achieving consistently positive treatmentresults isa challenge. Weconducted acontrolled clinical study ofa newtreatment approach (Neuromonics Tinnitus Treatment) that involves the useofa customized neural stimulus. Thisstimulusisdelivered tothepatientin theform of a pleasantacoustic sensation that isspectrally modifiedaccordingtoeach patient's individualaudiometric profile. This treatment approach is provided aspart ofa structured rehabilitation program. In our study, patients who received the customized stimulus (Neuromonics group) reported significantly greater and moreconsistent alleviation of tinnitus symptoms than did patients who participated in a counseling and support program with and without delivery of a broadband noise stimulus (Noise +Counseling group and Counseling-Only group, respectively).After6 monthsoftreatment, 86% oftheNeuromonics patients met the minimum criterion for clinical success, defined as an alleviation of tinnitus disturbance . of at least40% (as determined by the Tinnitus Reaction Questionnaire score). Bycontrast, only47 and23% of the Noise+Counseling and Counseling-Only groups, respec-
Introduction
Recent advances in our understanding of tinnitus pathogenesis have focused on the importance of the neurologic processes underlying this condition. 1 Consistent with these advances, several approaches have been proposed to combine counseling with acoustic therapy, usually in the form of noise generators or hearing aids.' Unfortunately, these approaches are limited by a lack of clinically consistent efficacy, efficiency, and/or user acceptability. Three such approaches-tinnitus masking, tinnitus retraining therapy, and cognitive behavioral therapywith noise generators-have recentlybeen demonstrated to yield only modest improvements, even when therapy was provided for as long as 18 months." Some investigators have questioned whether the acoustic stimulation used in these approaches provides any incremental benefit over the counseling component of the se programs.t" Furthermore, there are some reports of patient acceptability problems and high return rates with such devices .Y Development ofthe Neuromonics Tinnitus Treatment (Neuromonics Pty. Ltd.; Sydney, Australia) was undertaken to overcome the practical limitations of previous approaches." In particular, the goal of its developers was to provide a means of delivering acoustic stimulation that would more readily promote desensitization to patients' tinnitus perception in a manner that is more $149 per month* acceptable to patients than th e alternatives. As detailed elsewhere, the individually customized acoustic stimulus was designed to pro vide stimulation to the auditory pathways deprived by hearing loss, to engage positively with the limbic system , and to allow for intermittent, momentary tinnitus perception within the context of a pleasant and relaxing acoustic experience, thereby facilitating desensitization to the tinnitus signal ." The implementation of this novel treatment approach includes a clinician-administered support program that shares key elements with other counseling programs in general use and that incorporates princip les of cognitive behavioral therapy.I I The Neuromonics Tinnitus Treatment has been the subject of a series of clinical studies. In 2007 , we reported that this treatment resulted in great an d rapid improvements in tinnitus symptom scores for a large majority of suitable patients.'? After 6 months, 91% of patients with significant tinnitus disturbance reported an improvement in disturbance scores of at least 40% (mean improvement: 65%). Much ofthat improvement became evident over the first 2 months of treatment. That study also demonstrated the benefit ofthe customization process, which allows patients to cover up their tinnitus at a listening volume that is much lower (16 dB on average) than is the case with an equ ivalent noncustomized stimulus. The present study preceded that study. In the present study, we compared the Neuromonics Tinnitus Treatment with two other protocols: a counseling and support program with delivery of a broadband noise stimulus and one without.
Patients and methods
Study design. The present study was designed as a repeated-measures construction with allocation of patients into one of four parallel groups. All four gro ups participated in an in-depth educational, counseling, and support program, and each was given a copy of a self-help book on tinnitus strategies" and other written materials. P-" The individual group protocols were as follows:
Neuromonics group 1 (high interaction). Patients were provided with a customized acoustic stimulus in the form of music that had been spectrally modified according to each patient's audiometric profile and based on a specific algorithm.'? The music was transmitted via a portable sound player. Patients were ins tructed to listen to the music for a minimum of 2 hours per day, preferably when their tinnitus was usually most distur bing. They were asked to set th e volume to a level that just 332 • www.entjournal.com managed to cover up their tinnitus, provided that the level was not uncomfortable.
Neuromonics group 2 (intermittent interaction). The only difference between this group and Neuromonics group 1was that group 2 patients were instructed to set the volume to cover up their tinnitus for only about half the time-that is, to allow the tinnitus to be covered up during the dynamic stimulus' intensity peaks an d to be discernible during the intensity troughs.
Noise +Counselinggroup.These patients were provi ded with a stimulus th at em ulated the outp ut of a typical broadband noi se gene rator;th estimulus was rep roduced through th e same typ e of portable sound player used by the Neuromonics groups. Patients were instru cted to listen for as long as possible each day (m inimum: 2 hr/day), preferably when their tinnitus was usually most disturbing. They were asked to set the volume at the lowest level at which both the acoustic stimulus and the tinnitus could be heard, consistent with the "mixing point" recommendations of a tinnitus retraining therapy protocol."
Counseling-Only group. The patients in this group received no acoustic stimulus,but all other facets of their rehabilitation program were the same as they were for the other three groups. Additional time was devoted to the counseling component for these patients to ensure that they spent as much total time with a clin ician as did patients in the other gro ups (in the three acousticstimulus gro ups, clini cians spent time with patien ts to instruct them on how to use the acoustic -stimulus equipment) .
Th e study design was approved by th e Human Research Eth ics Committee of Curtin University of Technology's Division of Health SCiences (HREC approval No. 118/93) .
Measurement devices.
Clinical data were collected after 3, 6, and 12 months of treatment. The Tinnitus Reaction Q u estio n n aire (TRQ ) was the principal measurement instrument, chosen because of its wellestablished and robust psychometric properties, including its test -retest reliability, construct validity, and internal consistency, " The TRQ summates the degree of tinnitus distress over 26 items that are indicative of the extent oflifestyle distur bance, yielding a composite score ranging between a and 104. A threshold for a clinically significant improvement was set at 40% of the pretreatment TRQ value. At the high end of the range of percentage-improvement thres holds reported elsewhere. v":" th e more conservative th resh old was adopted in the presen t stu dy to ens ure that it wou ld In accordance with the method described by Coles," a visual analogue scale (VAS) was used to quantify changes in three parameters: tinnitus severity (in terms of how much it affected the patient's lifestyle), general relaxation level, and loudness tolerance (as determined by patients' sensitivity to loud sounds). The pretreatment VAS was anchored at 5; improvement was reflected as a reduction in scores moving toward 0, and deterioration was reflected as an increase in scores toward 10. While these measures are subjective, they are still valid because the clinical problem we are dealing with is the individual's subjective response to tinnitus. Consistent with the 40% minimum threshold for defining success according to the TRQ result, a 2-point downward movement was set as the minimum threshold for success with VAS scores, relative to the pretherapy anchor score of 5.
Each patient's TRQ and VAS scores reflected the effects of their tinnitus during the 7 days prior to each clinic visit . The TRQ and VAS forms were dispensed by the clinic administrator, and patients completed them unassisted so that they would not be subjected to any rater bias . .
Objective audiologic measurements, including puretone hearing thresholds and broadband noise minimum masking levels (MMLs), were obtained with a Maico MA53 audiometer and Sennheiser HDA200 headphones. The 10-and 12.5-kHz dB HL values were calibrated according to ISO TR/389-5. Psychoacoustic tinnitus measurements were based on the Oregon Health & Science University protocol. 23 At 12 months, a written treatment-completion survey was administered. Patients were asked to rate the degree of benefit they perceived on a scale of 0 to 4: not at all (0), a little of the time (1), some of the time (2), a good deal of the time (3), and almost all of the time (4). Their perceived benefits were based on the degree to which they felt the following statements applied to them in relation to their particular type of treatment:
• My particular treatment gave me a sense of control over my tinnitus.
• My tinnitus disturbs me less now.
• My particular treatment allowed me to relax.
• If my sleeping was disturbed by the tinnitus, my particular treatment helped me get to sleep.
• My tinnitus seems softer overall.
Finally,patients were asked if they enjoyed the acoustic 
Patients.
A total of 88 participants were recruited through a variety of sources. The first enrolled patient was placed into a treatment group by random selection. Patients were subsequently placed by alternating them among groups, the order of which was also randomly determined, thereby ensuring that there was no groupselection bias for individual patients. All patients had undergone a recent ENT evaluation to confirm that medical treatment for their tinnitus was not feasible. Patients neither paid for their treatment nor were reimbursed for their time and expenses.
Nineteen patients were excluded on the basis of the following criteria:
•a significant hearing loss in the speech range, defined as a four-frequency (0.5-, 1-,2-, and 4-kHz) average hearing threshold level of greater than 70 dB in the better-hearing ear;
• ongoing monetary compensation claims related to tinnitus",
• clinically significant psychosis, depression, cognitive incapacity, or insufficient fluency in the English language;
• a level of tinnitus-related disturbance that was not clinically significant, as indicated by a TRQ score of less than 17 17 ; • continued exposure to any significant condition that can aggravate tinnitus, such as loud noise, ototoxic medication, or a disease process; and . •concurrent treatment for tinnitus (including a recent onset ofhearing aid use) that exceeded 1hour per day (7 regular users of hearing aids were enrolled in the study, no more than 3 in any group).
Five patients who reported suicidal ideation in their initial questionnaires were allowed to choose whichever treatmenttheywished, and they were therefore excluded from the dataset for analysis. Also, at the post-waiting list/pretreatment repeat administration of the TRQ, 14 patients reported a score lower than the threshold of 17, and they too were excluded from the dataset.
We were thus left with 50 patients-26 males and 24 females,with a mean ageof 49.8years (standard deviation [SD]: 15.8; range: 17 to 74). The mean length oftime that their tinnitus had been disturbing was 3.6 years (SD: 4.1; range 0.2 to 23). It is the authors' opinion that our sample was representative of the type of patients who www.entjournal.com • 333 DAVIS, WILDE, STEED, HANLEY would be recommended for a rehabilitation program by a typical tinnitus clinic.
Of the 50 patients, 13 were in Neuromonics group 1, 9 in Neuromonics group 2,15 in the Noise+Counseling group, and 13 in the Counseling-Only group. Of these, 5 were subsequently lost to follow-up prior to study completion-2 in Neuromonics group 2 (after 6 mo ), 1 in the Noise+Counseling group (after 3 mo), and 2 in the Counseling-Only group (1 after commencement of treatment and 1 after 3 mo). All patients lost to followup were included in the dataset for analysis on a "last value carried forward" basis. Any gaps in the dataset arising from appointments not kept or measurements not performed were also addressed in this way.
The mean pretreatment TRQ score for the 50 patients was 39.3 (SD: 18.0; range: 17 to 91). This mean level corresponds with a moderate to severe level of tinnitus disturbance relative to the normative data collated by the TRQ's developers. "
Clinical procedure. The clinical sessions included an assessment appointment, a device-fitting appointment, a 2-week postfitting review, and follow-up appointments at 3, 6, and 12 months after fitting. Patients in all treatment groups participated in an individualized counseling and support program as described in more detail elsewhere." Essentially, the pathogenesis of their tinnitus was explained to them in lay terms based on the model described by Jastreboff and Hazell" and related back to their own test results and case history. A collaborative style was adopted that involved interactive dialogue consistent with the essential principles of cognitive behavioral therapy," Care was taken to create a nurturing atmosphere in which patients could describe their experience of tinnitus and their emotional reaction to it. Practical strategies were discussed, including avoidance of silence, avoidance of overprotection, and avoidance ofloud noises.In the three acoustic-treatment groups, coping strategies were encouraged as an interim measure until desensitization occurred. Relaxation training was also provided, facilitated by the use of the acoustic stimulus. .
Written patient education materials were provided to ensure consistency of communication, to reinforce and consolidate key messages at home after appointments, to educate family members, and to overcome reliance on verbal communication with the hearing-impaired. These comprised a self-help book," an insert authored by Coles and Hazell" and supplied with the book by the RoyalNational Institute for DeafPeople, and a handout to challenge patients' thinking about their tinnitus, 334 • www.entjournal.com incorporating the 11 most typical "negative tinnitus beliefs" as initially described by Hazell. 14 These materials were dispensed as "homework; ' and the relevance of the issues they cover were later explored during the development of individual strategies.
Statistical analysis. Descriptive statistics were used for all outcomes, and parametric inferential methods for continuous and categorical outcomes were used as required. When required, due care was devoted to using methods that accounted for repeated measures. For continuous outcomes, t tests or Wald tests were performed for two-group comparisons, and repeatedmeasures analysis of variance (ANOVA) was used for more than two. Chi-squared (X 2 ) tests and logistic and multinomial-logistic regression analyses were used for discrete outcomes. Descriptive statistics were compiled on Excel 2002 software, and inferential analyses were conducted with Stata software (v9. 2; 2005) .
Pooling ofdatafor theNeuromonicsgroups. After the conclusion of the study,wediscovered that many patients in the two Neuromonicsgroups had ,oftheir own accord, deviated from the volume settings prescribed for them. Many patients in Neuromonics group 1 (high interaction ) had opted for a lower volume setting in order to achieve a more intermittent or partial interaction with their tinnitus perception, while a number of patients in Neuromonics group 2 (intermittent interaction) had initially used a higher volume setting to completely cover up their tinnitus. These deviations appeared to be a result of the patients' tendency to self-administer the treatment in a manner that they felt "worked best" for them on a day-to-day basis. As a consequence, at a practical level, the treatments received by the patients in these two groups were much more similar than we had originally intended when we formulated the group design. After we learned of this, a reanalysis of the TRQ scores revealed no statistically significant differences between the two Neuromonics groups either at the global level (x\ = 1.24, p =0.744) or for any individual time interval (t = -0.64 to -1.09, P> 0.28 at any time point).
In light of these considerations, the two Neuromonics groups were pooled for all analyses of results reported herein , and the two groups are henceforth referred to collectively as the Neuromonics group.
Results
Daily device use. During the course of treatment, the patients in the Neuromonics group reported that they used their device an average of 1. Visual analogue scale. Mean VAS scores after 12 months are displayed in figure 2 for three different dimensions: tinnitus severity, general level of relaxation, and loudness tolerance. A statistically significant improvement over baseline values was evident in all three dimensions in the Neuromonics group (ANOVA: t = -12.86, P < 0.001 for tinnitus severity; t =-11.23, P< 0.00 1 for general relaxation; t = -4.86, P< 0.00 1 for loudness tolerance). Improvements were more modest in the other groups and were not statistically significant. A deterioration in the mean score for loudness tolerance was apparent in the Counseling-Only group, but this change was not statistically significant.
Intergroup differences were statistically significant between the Neuromonics and Noise+Counseling ment, patients were asked to rate the degree of benefit they perceived in various aspects of their tinnitus experience and general well-being. Figure 5 shows the proportion of patients who provided a rating of 3 or 4 on a scale of 0 (not at all) to 4 (almost all of the time) for each parameter. A high proportion of patients in the Neuromonics group reported substantial perceived benefits (control of tinnitus: 86%; less disturbance from tinnitus: 68%;greater relaxation: 86%; improved sleep: 63%; softer tinnitus: 64%). Again, much less benefit • TRQ score: an improvement of at least 40%
• MML: an improvement of at least 5 dB (among those whose pretreatment MML was 5 dB)
• VAS scores for tinnitus severity, general relaxation, and tolerance for loud sounds: a 2-point decrease relative to a starting point of 5 on a scale of 0 to 10 groups (repeated-measures ANOVA: z = -4.35,p< 0.001 for tinnitus severity; z=-3.67, p = 0.001 for general relaxation; z = -2.45, P = 0.018 for loudness tolerance) and between the Neuromonics and Counseling-Only groups (z = -:-4.00, p < 0.001 for tinnitus severity; z = -3.08, P = 0.003 for general relaxation; z = -4.22, P < 0.001 for loudness tolerance), but not between the Noise+Counseling and Counseling-Only groups (z = 0.15, P = 0.884 for tinnitus severity; z = 0.39, P = 0.696 for general relaxation; z = -1.73, P = 0.091 for loudness tolerance).
Audiometric minimum masking levels.
MMLs reported for each group at 6 and 12 months are displayed in figure 3. Significant improvements over baseline were seen in the Neuromonics group at6 months (mean change: 9.9 dB; repeated-measuresANOVA: z =-4.40, p <0.001) andat 12months (mean change: 11 
Clinical significance and consistency of benefit.
Consistency of efficacy is a key consideration in comparing different treatment modalities. Figure 4 displays the proportion of patients in each group who reported benefit at a level at or greater than a specified threshold relevant to that measure at 12 months. These thresholds were:
A high proportion of patients in the Neuromonics group experienced a sizable degree of perceived benefits . Less consistent benefit was reported by patients in the other two groups.
Benefit ratings. After 12 months of treat- with noise generators. For example, in 2005, Henry et al found that only 19% of patients who were provided with tinnitus masking and 29% of those who underwent tinnitus retraining therapy reported clinicallysignificant improvement after 6 months; by 12 months, the corresponding figures were 30 and 55%.2In that study, clinicallysignificant improvement was defined as a reduction in score of at least 20 points on the 100-point Tinnitus Inventory Handicap scale among those patients who se pretreatment score had exceeded 20 points. Successrates were determined after excluding the 10% of patients who did not complete treatment. Mean improvements in the tinnitus masking group and the tinnitusretraining therapy group were approximately 17and 26%, respectively, after 6 months and 21 and 42% after 12 months.
The same year, Hiller and Haerkotter described their study of cognitive behavioral therapy with and without noise generators. ' Mean improvements in tinnitus disturbance scores were 41 and 31%, respectively, for patients with moderate and severepretreatment disturbance after 6 months, and 38 and 35% after 18 months.
In the present study, patients who underwent Neuromonics treatment reported significant benefit on other tinnitus measures besides the TRQ, such as lower MMLs, improved VAS scores of tinnitus severity, and improved ratings of tinnitus control and disturbance. They also reported significant benefits on measures Figure 5 . Chart data reflect the degree of benefit report ed at study's end. The bars represent the proportion of patients in eachgroupwho reporteda benefit score of 3 or 4 on a scale of 0 (no benefit) to 4 (almost allof the time) for each measured outcome. The differences between the Neuromonics and Noise+Counseling groups were significant for all parameters: tinnitus control (p = 0.001), less disturbance (p = 0.006), greater relaxation (p < 0.001), improved sleep (p =0.001),and softer tinnitus (p =0.023). The differences between the Neuromonics and Counseling-Onl y groups weresignificant forgreaterrelaxation (p < 0.001 ) and improved sleep (p = 0.007). There were no significant differences between the Noise+Counseling and Counseling-Only groups.
Discussion
Clinical efficacy. Among patients who underwent the Neuromonics Tinnitus Treatment program, considerable improvements in tinnitus-related distress (as measured byTRQ score) were evident in the first few months of treatment, with further changes apparent up to 12 months. Mean improvement on this measure was 61% at 6 months and 66% at 12 months. This translates into a large,positive impact on the lifestyleeffects oftinnitus. The overall success rate (defined as the proportion of patients who reported an improvement in tinnitus disturbance of40% or greater) was 86% ofall Neuromonics patients after 6 months of treatment.
These improvements in tinnitus-related disturbance compare favorably with the results of published studies of other approaches in which counseling was combined with acoustic therapy, such as tinnitus retraining therapy, tinnitus masking, and cognitive behavioral therapy was seen in the other groups.
Differences between the Neuromonics and Noise+Counseling groups were significant for all parameters (repeated-measures ANOVA: z = 3.67, P = 0.001 for tinnitus control; z = 2.90, P = 0.006 for less disturbance; z = 4.37, P < 0.001 for greater relaxation; z = 3.38, P = 0.001 for improved sleep; z= 2.36, p= 0.023 for softer tinnitus) . Differences between the Neuromonics and Counseling-Only groups were significant for greater relaxation (z=4.07,p < 0.001) and improved sleep (z = 2.89, P= 0.007) . There were no significant differences between the Noise+Counseling and Counseling-Only groups.
User satisfaction. In the posttreatment questionnaire administered after 12 months, patients were asked to rate the degree to which they enjoyed the acoustic stimulus provided on a scale of 0 (not at all) to 4 (almost all of the time). Some 73% of the Neuromonics group rated their enjoyment at least a 3, compared with only 17% who were provided broadband noise. When asked if they sometimes tired of hearing the acoustic stimulus, the proportions of patients who rated at least a 3 on the same scale were 9 and 8%, respectively.
